Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of
Clinical Cardiology ISSN: 2378-2951

Citation

Jae-Jin K, Doh JH, Lee SY (2019) Effects of Bisoprolol and Flecainide in an Elderly Patient with Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation in Wolff-Parkinson-White Syndrome. Int J Clin Cardiol 6:138. doi.org/10.23937/2378-2951/1410138

Copyright

© 2019 Jae-Jin K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

CASE REPORT | OPEN ACCESSDOI: 10.23937/2378-2951/1410138

Effects of Bisoprolol and Flecainide in an Elderly Patient with Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation in Wolff-Parkinson-White Syndrome

Jae-Jin Kwak*, Joon Hyung Doh and Sung Yun Lee

Division of Cardiology, Department of Internal Medicine and Cardiovascular Center, Inje University Ilsan Paik Hospital, South Korea

Abstract

Wolff-Parkinson-White (WPW) syndrome can develop paroxysmal supraventricular tachycardia (PSVT) or/and paroxysmal atrial fibrillation (AF). AF in WPW syndrome is a potentially life-threatening arrhythmia. Radiofrequency catheter ablation is recommended in patients with AF in WPW syndrome. Atrioventricular nodal blockers can precipitate ventricular fibrillation and should not be used. We present patients with PSVT and AF in WPW syndrome who was treated with bisoprolol and flecainide.